Breast Cancer Awareness Part 3
Read Moreinsights - Blog Posts
Article 2: Evolution of the Biosimilars Industry
Our first white paper, Biosimilars Come of Age, highlighted growth...
Read More
Handling of COVID-19 infection in Employees – Summary Report (Jun-20)
Based on FDA guidance on GMP considerations for Responding to...
Read More
Article 1: Biosimilars Come of Age
In the 1990s, it was “generic biologics”. In the early...
Read More
IBPS Covid-19 CT Update III (05-May-20)
IBPS and SBLehrer LLC are releasing the next update of...
Read More
IBPS Covid-19 CT Update II (04-Apr-20)
IBPS and SBLehrer LLC are releasing the next update of...
Read More
IBPS Covid-19 CT Update I (09-Apr-20)
COVID-19 has many names; Coronavirus, Covid-19 or SARS-CoV-2. Worldwide pandemic...
Read More
Biosimilar Market Trends 2018
Global biosimilar market is currently driven by presence of a...
Read More
Pragmatic Implementation of Clinical Trials
An Indian generic pharmaceutical giant was keen on developing in-house...
Read More
Is India the next hub for Technical Writing for Drug Development?
how technical writing opportunities have proliferated in the drug development...
Read More
Regulatory requirement for Biosimilar Development – Purpose, Innovation and Cost
As the regulatory landscape is evolving for biosimilars, the intriguing...
Read More
Can India be saved from the Breast Cancer epidemic staring at it???
October being the Breast Cancer awareness month, we thought that...
Read More